Showing results (1241-1250 of 3,105) with videos related to

Sort By:
Pageof 311
Drug Safety|January 9, 2020
Towards Automating Adverse Event Review: A Prediction Model for Case Report UtilityMonica A Muñoz, Gerald J Dal Pan, Yu-Jung Jenny Wei, et al.
Drug Safety|February 3, 2020
Disproportionality Analysis for Pharmacovigilance Signal Detection in Small Databases or Subsets: Recommendations for Limiting False-Positive AssociationsOla Caster, Yasunori Aoki, Lucie M Gattepaille, et al.
Drug Safety|February 6, 2020
Quality of Reporting on the Evaluation of Risk Minimization Programs: A Systematic ReviewAndrea M Russell, Elaine H Morrato, Rebecca M Lovett, et al.
Drug Safety|December 19, 2019
A Post-Authorization Safety Study of Quetiapine as Antidepressant Treatment in Sweden: Nested Case-Control Analyses of Select OutcomesJohan Reutfors, Philip Brenner, Bob Brody, et al.
Drug Safety|May 17, 2022
Artificial Intelligence and Machine Learning for Safe MedicinesAndrew Bate, Yuan Luo
Drug Safety|May 17, 2022
"Artificial Intelligence" for Pharmacovigilance: Ready for Prime Time?Robert Ball, Gerald Dal Pan
Drug Safety|May 17, 2022
Industry Perspective on Artificial Intelligence/Machine Learning in PharmacovigilanceRaymond Kassekert, Neal Grabowski, Denny Lorenz, et al.
Drug Safety|May 17, 2022
Intelligent Telehealth in Pharmacovigilance: A Future PerspectiveHeba Edrees, Wenyu Song, Ania Syrowatka, et al.
Drug Safety|June 1, 2022
Montelukast and Nightmares: Further Characterisation Using Data from VigiBaseSarah Watson, Elenor Kaminsky, Henric Taavola, et al.
Drug Safety|May 23, 2022
Chemobrain in Breast Cancer: Mechanisms, Clinical Manifestations, and Potential InterventionsGiovana R Onzi, Nathalia D'Agustini, Solange C Garcia, et al.
Pageof 311